Key Sessions
Realizing the Promise of CRISPR Therapeutics
RaPID Display and Selection of Pseudo-natural Products
The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook
Clinical Update on Oligonucleotides for Cardiovascular Disease
Antibody Oligonucleotide Conjugates (AOCs): RNA Delivery Beyond the Liver
“I Love Conjugates”: The GalNAc Revolution and Its Impact on Oligonucleotide Therapeutic Development
Main Conference - Day 1 Keynote Sessions (May 12)
search
Streams
6:30am - 7:30am60 mins
Registration
Breakfast Spotlight Presentations
7:30am - 8:00am30 mins
Breakfast Spotlight Presentations 1
Balanced Chemistry in Peptide Therapeutics
- Susan Li, PhD - Peptide Chief Scientist, Asymchem
7:30am - 8:00am30 mins
Breakfast Spotlight Presentations 3
Driving Further Evolution in Peptide API Downstream Processing
- Yoshitaka Nemoto - Vice President R&D, PeptiStar
8:10am - 8:15am5 mins
Keynote and Plenary Session
Chairperson’s Remarks: Keynote Day 1
8:15am - 9:00am45 mins
Keynote and Plenary Session
The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook
9:00am - 9:45am45 mins
Keynote and Plenary Session
“I Love Conjugates”: The GalNAc Revolution and Its Impact on Oligonucleotide Therapeutic Development
9:45am - 10:15am30 mins
Networking Refreshment Break
Morning Keynote Session
10:15am - 11:00am45 mins
Keynote and Plenary Session
Realizing the Promise of CRISPR Therapeutics
11:00am - 11:45am45 mins
Keynote and Plenary Session
Oligonucleotide Therapeutics: Current Challenges and Opportunities
11:45am - 12:05pm20 mins
Transition to Spotlight Presentation/Panel Luncheons
Spotlight Presentation Luncheons
12:05pm - 12:35pm30 mins
Spotlight Presentation Luncheon 3
Hongene Luncheon Presentation
- David Butler, PhD - Chief Technology Officer, Hongene Biotech Corporation
12:05pm - 12:35pm30 mins
Spotlight Presentation Luncheon 4
Improving CRISPR genome editing efficiency by optimized manufacturing methods for high-purity modified gRNAs.
- Toshifumi Kano - Research Associate, Sumitomo Chemical Europe
12:05pm - 12:35pm30 mins
Spotlight Luncheon Presentation 5
Supporting Clients from Pre-Clinic to Commercial: Using the Wigman Model to Strategize GMP Process Development
- Amy Druschitz - Technical Business Development Manager, Croda
12:35pm - 12:55pm20 mins
Short Networking Break
Afternoon Keynote Session
12:55pm - 1:00pm5 mins
Keynote and Plenary Session
Chairperson’s Remarks: Keynote Day 1
1:00pm - 1:45pm45 mins
Keynote and Plenary Session
Clinical Update on Oligonucleotides for Cardiovascular Disease
1:45pm - 2:30pm45 mins
Keynote and Plenary Session
Antibody Oligonucleotide Conjugates (AOCs): RNA Delivery Beyond the Liver
2:30pm - 3:30pm60 mins
Grand Opening of Poster and Exhibit Hall and Networking Refreshment Break
3:30pm - 4:15pm45 mins
Keynote and Plenary Session
RaPID Display and Selection of Pseudo-natural Products
4:15pm - 5:00pm45 mins
Keynote and Plenary Session
Panel Discussion: Addressing the Challenges of Bringing New Therapeutic Modalities to Market: Technical and Regulatory Considerations
5:00pm - 6:30pm90 mins
Networking Reception in Poster and Exhibit Halls
* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.